Miles Nunn
Directeur Technique/Scientifique/R&D chez AKARI THERAPEUTICS, PLC
Fortune : - $ au 31/07/2023
Postes actifs de Miles Nunn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AKARI THERAPEUTICS, PLC | Directeur Technique/Scientifique/R&D | 01/09/2015 | - |
Historique de carrière de Miles Nunn
Anciens postes connus de Miles Nunn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Evolutec Group Plc
 Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Corporate Officer/Principal | - | - |
| Amplion Ltd. | Directeur/Membre du Conseil | - | - |
Volution Immuno Pharmaceuticals SA
 Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Directeur Technique/Scientifique/R&D | 01/04/2014 | - |
Formation de Miles Nunn
| University of Oxford | Doctorate Degree |
| University College London | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 5 |
| Suisse | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AKARI THERAPEUTICS, PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Evolutec Group Plc
Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Health Technology |
Volution Immuno Pharmaceuticals SA
Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Health Technology |
| Amplion Ltd. |
- Bourse
- Insiders
- Miles Nunn
- Expérience